HilleVax (HLVX)
(Delayed Data from NSDQ)
$1.84 USD
-0.10 (-5.15%)
Updated Jul 24, 2024 04:00 PM ET
After-Market: $1.84 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
D Value D Growth B Momentum D VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
HLVX 1.84 -0.10(-5.15%)
Will HLVX be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for HLVX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for HLVX
Down -88.84% in 4 Weeks, Here's Why HilleVax (HLVX) Looks Ripe for a Turnaround
Biotech Stock Roundup: KYMR, IDYA, QURE Soar on Study Data, HLVX Tanks on Study Failure
HLVX: What are Zacks experts saying now?
Zacks Private Portfolio Services
HilleVax (HLVX) Tanks as Norovirus Vaccine Study in Infants Fails
Wall Street Analysts Believe HilleVax, Inc. (HLVX) Could Rally 92.19%: Here's is How to Trade
HilleVax, Inc. (HLVX) Moves to Buy: Rationale Behind the Upgrade
Other News for HLVX
HilleVax Reports Topline Data from NEST-IN1 Phase 2b Clinical Study of HIL-214 in Infants
Why Core & Main Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Saia, Annexon, Core Scientific And Other Big Stocks Moving Higher On Tuesday
Why Applied DNA Sciences Shares Are Trading Lower By Around 68%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Director Aditya Kohli Sells 18,000 Shares of HilleVax Inc (HLVX)